Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 2947-2949, July 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radford, D. M.
Right arrow Articles by Donis-Keller, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radford, D. M.
Right arrow Articles by Donis-Keller, H. R.

Allelic Loss on Chromosome 17 in Ductal Carcinoma in Situ of the Breast1

Diane M. Radford2, Keri Fair, Alastair M. Thompson, Jon H. Ritter, Matthew Holt, Todd Steinbrueck, Mairi Wallace, Samuel A. Wells, Jr. and Helen R. Donis-Keller

Divisions of Human Molecular Genetics [D. M. R., K. F., M. H., T. S., S. A. W., H. R. D-K.], and General Surgery [D. M. R., S. A. W.]; Department of Pathology [J. H. R.], Washington University School of Medicine, St. Louis, Missouri 63110; Department of Surgery [A. M. T.], University of Edinburgh, Edinburgh, Scotland EH6 9YW; and MRC Human Genetics Unit [M. W.], Western General Hospital, Edinburgh, Scotland

Multiple tumor suppressor genes are implicated in the oncogenesis and progression of invasive carcinoma of the breast. To investigate the chronology of genetic changes we studied loss of heterozygosity on chromosome 17 in ductal carcinoma in situ, a preinvasive breast cancer. A micro-dissection technique was used to separate tumor from normal stromal cells prior to DNA extraction and loss of heterozygosity was assayed mainly using simple sequence repeat polymorphism markers and the polymerase chain reaction. Loss of heterozygosity on 17p was observed in 8 of 28 tumors (29%) when compared with normal control DNA, whereas no loss was seen on 17q, suggesting that at least one locus on 17p is involved early in the development of breast cancer.

1 These studies were supported in part by a VA RAG Grant and ACS Grant #42048R (to D.M.R.), NIH Grant HG00304 (to H. D-K.).

2 To whom requests for reprints should be addressed, at Suite 6104, Queeny Tower, One Barnes Hospital Plaza, St. Louis, MO 63110.

Received 3/31/93. Accepted 5/18/93.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
F. Fend and M. Raffeld
Laser capture microdissection in pathology
J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
X. Cui, H. Feiner, Z. Lin, and H. Li
Multiplex Genotype Analysis of Invasive Carcinoma and Accompanying Proliferative Lesions Microdissected from Breast Tissue
J. Mol. Diagn., February 1, 2000; 2(1): 29 - 36.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
F. Fend, M. R. Emmert-Buck, R. Chuaqui, K. Cole, J. Lee, L. A. Liotta, and M. Raffeld
Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis
Am. J. Pathol., January 1, 1999; 154(1): 61 - 66.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.